CDA regulates the metabolism of epigenetic nucleosides revealing a therapeutic window in cancer, especially in pancreatic cancer, that has CDA overexpression and is resistant to treatment with other cytidine analogs 43, 44. The gene discussed is CDA; the disease is pancreatic neoplasm.